India caps cancer drug prices after court rules mark-ups extortionate

India's government will cap prices on 137 cancer drugs starting next month, following a Supreme Court ruling that deemed excessive mark-ups 'extortion'. The case was brought by a retired bank clerk in 2022, highlighting the financial ruin facing poorer patients. This is a significant policy shift aimed at improving drug affordability, though implementation and impact on supply remain to be seen.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works